Brokerage firm Jefferies has initiated coverage on Cohance Lifesciences with a “buy” recommendation on Monday, August 25. The stock gained over 1% in response.Jefferies has a price target of ₹1,150 on Cohance Lifesciences, which implies a potential u…
Stocks To Buy: Jefferies initiates on this contract manufacturer for 30% upside, upgrades Divi’s
